NDC 51662-1459
AMIDATE(TM) ETOMIDATE
Amidate(tm) Etomidate
AMIDATE(TM) ETOMIDATE is a Intravenous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Hf Acquisition Co Llc, Dba Healthfirst. The primary component is Etomidate.
| Product ID | 51662-1459_a227d2f1-3ef0-4ac6-e053-2995a90a5340 |
| NDC | 51662-1459 |
| Product Type | Human Prescription Drug |
| Proprietary Name | AMIDATE(TM) ETOMIDATE |
| Generic Name | Amidate(tm) Etomidate |
| Dosage Form | Injection, Solution |
| Route of Administration | INTRAVENOUS |
| Marketing Start Date | 2020-03-31 |
| Marketing Category | NDA / NDA |
| Application Number | NDA018227 |
| Labeler Name | HF Acquisition Co LLC, DBA HealthFirst |
| Substance Name | ETOMIDATE |
| Active Ingredient Strength | 2 mg/mL |
| Pharm Classes | General Anesthesia [PE],General Anesthetic [EPC] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2021-12-31 |